These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural course of retinal development in preterm infants without threshold retinopathy. Jandeck C; Kellner U; Helbig H; Versmold H; Foerster MH Ger J Ophthalmol; 1995 May; 4(3):131-6. PubMed ID: 7663325 [TBL] [Abstract][Full Text] [Related]
3. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone. Uparkar M; Sen P; Rawal A; Agarwal S; Khan B; Gopal L Int Ophthalmol; 2011 Feb; 31(1):3-8. PubMed ID: 21194006 [TBL] [Abstract][Full Text] [Related]
4. The predictive value of posterior pole vessels in retinopathy of prematurity. Saunders RA; Bluestein EC; Sinatra RB; Wilson ME; O'Neil JW; Rust PF J Pediatr Ophthalmol Strabismus; 1995; 32(2):82-5. PubMed ID: 7629674 [TBL] [Abstract][Full Text] [Related]
5. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]. Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695 [TBL] [Abstract][Full Text] [Related]
6. Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. Tahija SG; Hersetyati R; Lam GC; Kusaka S; McMenamin PG Br J Ophthalmol; 2014 Apr; 98(4):507-12. PubMed ID: 24403566 [TBL] [Abstract][Full Text] [Related]
7. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity]. Huang ZN; Yin DM; Huang DR; Liang SX Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127 [TBL] [Abstract][Full Text] [Related]
8. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Palmer EA; Flynn JT; Hardy RJ; Phelps DL; Phillips CL; Schaffer DB; Tung B Ophthalmology; 1991 Nov; 98(11):1628-40. PubMed ID: 1800923 [TBL] [Abstract][Full Text] [Related]
9. Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity study. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Quinn GE; Dobson V; Biglan A; Evans J; Plotsky D; Hardy RJ Arch Ophthalmol; 1995 Apr; 113(4):469-73. PubMed ID: 7710397 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of retinopathy of prematurity]. Heckmann M Ophthalmologe; 2008 Dec; 105(12):1101-7. PubMed ID: 19048259 [TBL] [Abstract][Full Text] [Related]
11. Management of avascular peripheral retina in older prematurely born infants. Ho LY; Ho V; Aggarwal H; Ranchod TM; Capone A; Trese MT; Drenser KA Retina; 2011; 31(7):1248-54. PubMed ID: 21358456 [TBL] [Abstract][Full Text] [Related]
12. Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study. Wheeler DT; Dobson V; Chiang MF; Bremer DL; Gewolb IH; Phelps DL; Hardy RJ; Good WV; Fellows R; Tung BP; Palmer EA Ophthalmology; 2011 Jun; 118(6):1145-51. PubMed ID: 21211840 [TBL] [Abstract][Full Text] [Related]
13. The possible effect of pentoxifylline on development and severity of retinopathy of prematurity. Erbaş İM; Çetinkaya M; Yıldız Ekinci D; Yılmaz Semerci S Cutan Ocul Toxicol; 2021 Dec; 40(4):359-364. PubMed ID: 34429007 [TBL] [Abstract][Full Text] [Related]
14. RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study. Lorenz B; Stieger K; Jäger M; Mais C; Stieger S; Andrassi-Darida M Retina; 2017 Jan; 37(1):97-111. PubMed ID: 27454223 [TBL] [Abstract][Full Text] [Related]
15. Retinal vascular development in an immature retina at 33-34 weeks postmenstrual age predicts retinopathy of prematurity. Jang JH; Kim YC Sci Rep; 2020 Oct; 10(1):18111. PubMed ID: 33093504 [TBL] [Abstract][Full Text] [Related]
16. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. Johnson L; Quinn GE; Abbasi S; Gerdes J; Bowen FW; Bhutani V J Pediatr; 1995 Oct; 127(4):632-9. PubMed ID: 7562291 [TBL] [Abstract][Full Text] [Related]
17. Natural history of retinopathy of prematurity: a prospective study. Fielder AR; Shaw DE; Robinson J; Ng YK Eye (Lond); 1992; 6 ( Pt 3)():233-42. PubMed ID: 1446754 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression. Vural A; Ekinci DY; Onur IU; Hergünsel GO; Yiğit FU Int Ophthalmol; 2019 Oct; 39(10):2267-2274. PubMed ID: 30604251 [TBL] [Abstract][Full Text] [Related]
19. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program. Onofrey CB; Feuer WJ; Flynn JT Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259 [TBL] [Abstract][Full Text] [Related]
20. [The results of diode treatment of active phase of retinopathy of prematurity]. Gotz-Wieckowska A; Kociecki J; Burchardt-Kroll E; Gadzinowski J Klin Oczna; 2003; 105(6):395-7. PubMed ID: 15049263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]